Related content

Combining AZD8931, a novel EGFR/HER2/HER3 signalling inhibitor, with AZD5363 limits AKT inhibitor induced feedback and enhances antitumour efficacy in HER2-amplified breast cancer models

By Crafter Claire   Vincent John P.   Tang Eric   Dudley Phillippa   James Neil H.   Klinowska Teresa   Davies Barry R.  

International Journal of Oncology, Vol. 47, Iss. 2, 2015-08 ,pp. : 446-454

Spandidos Publications

Access to resources Recommend Favorite

Macrophage Migration Inhibitory Factor in Cancer

By Yasasever Vildan   Camlica Hakan   Duranyildiz Derya   Oguz Hilal   Tas Faruk   Dalay Nejat  

Cancer Investigation, Vol. 25, Iss. 8, 2007-11 ,pp. : 715-719

Informa Healthcare

Access to resources Recommend Favorite

NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations

By              

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 1259-1266

Spandidos Publications

Access to resources Recommend Favorite

Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2451-2458

Spandidos Publications

Access to resources Recommend Favorite

Cancer upregulated gene 2, a novel oncogene, enhances migration and drug resistance of colon cancer cells via STAT1 activation

By Malilas Waraporn   Koh Sang Seok   Kim Seokho   Srisuttee Ratakorn   Cho Il-Rae   Moon Jeong   Yoo Hwa-Seung   Oh Sangtaek   Johnston Randal N.   Chung Young-Hwa  

International Journal of Oncology, Vol. 43, Iss. 4, 2013-10 ,pp. : 1111-1116

Spandidos Publications

Access to resources Recommend Favorite